PneumoSTAR Myco (Canada)This page contains information on PneumoSTAR Myco for veterinary use.
The information provided typically includes the following:
- PneumoSTAR Myco Indications
- Warnings and cautions for PneumoSTAR Myco
- Direction and dosage information for PneumoSTAR Myco
PneumoSTAR MycoThis treatment applies to the following species:
Mycoplasma Hyopneumoniae Bacterin
For Use in Animals Only
PneumoSTAR Myco Indications
For use in healthy swine as an aid in the prevention of pneumonia caused by Mycoplasma hyopneumoniae for a period of 23 weeks following vaccination.
Directions For Use
Shake well before using. Administer 1 mL intramuscularly at 3 weeks of age or older. For herds that need to use a 2 dose program (extreme stress/disease challenge), a second dose should be administered 2 or more weeks following the first dose.
PrecautionsStore out of direct sunlight at 2°C-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains thimerosal as a preservative.
U.S. Vet. License No. 303
Novartis Animal Health US, Inc.
© 2012 Novartis; Registered trademarks of Novartis AG, used under license.
Novartis Animal Health Canada Inc., Mississauga, Ontario, Canada L5N 1V9
NAC No.: 1231104.1
Distributed by ELANCO, Division Eli Lilly Canada Inc. & ELANCO CANADA LIMITED (successor to Novartis Animal Health Canada Inc.)
RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
|Elanco Canada Limited Customer Service Telephone:||800-387-6325|
|Elanco Canada Limited Customer Service Fax:||800-827-5782|
|Every effort has been made to ensure the accuracy of the PneumoSTAR Myco information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-05-31